| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2018 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Chairman, President And CEO | Sell | 150,000 | $25.27 | $3,790,938.86 | -15.3% | |
| Jun 11, 2018 | NBIX Neurocrine Biosciences Inc | Sherwin Stephen A | Director | Sell | 10,000 | $98.44 | $984,420.00 | -17.4% | |
| Jun 11, 2018 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 51,198 | $86.38 | $4,422,636.83 | - | |
| Jun 11, 2018 | EBS Emergent Biosolutions Inc. | Joulwan George A | Director | Sell | 5,000 | $52.89 | $264,447.50 | -14.2% | |
| Jun 8, 2018 | SNY Sanofi | Sanofi | 10% Owner | Sell | 121,601 | $309.31 | $37,611,882.43 | -0.5% | |
| Jun 8, 2018 | CANN Trees Corp (colorado) | Whitson Shelly | Chief Administrative Officer | Sell | 38,051 | $3.80 | $144,650.88 | -100% | |
| Jun 8, 2018 | DVAX Dynavax Technologies Corp | Ostrach Michael S | Senior Vice President | Sell | 4,000 | $15.53 | $62,100.00 | -5.0% | |
| Jun 7, 2018 | ESPR Esperion Therapeutics, Inc. | Biotech Target N V55 | 10% Owner | Buy | 60,000 | $37.79 | $2,267,292.00 | +2.0% | |
| Jun 7, 2018 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 18,406 | $36.28 | $667,764.48 | -6.6% | |
| Jun 7, 2018 | PAHC Phibro Animal Health Corp | Bendheim Jack52 | President And CEO | Sell | 30,000 | $46.06 | $1,381,650.28 | -15.8% | |
| Jun 7, 2018 | PAHC Phibro Animal Health Corp | Bfi Co., LLC | 10% Owner | Sell | 30,000 | $46.06 | $1,381,650.28 | -15.8% | |
| Jun 6, 2018 | EBS Emergent Biosolutions Inc. | Zoon Kathryn C62 | Director | Sell | 376 | $52.81 | $19,856.56 | -1.6% | |
| Jun 6, 2018 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 7,342 | $53.00 | $389,126.00 | -25.9% | |
| Jun 5, 2018 | EBS Emergent Biosolutions Inc. | Abdun-Nabi Daniel | Chief Executive Officer | Sell | 15,785 | $52.11 | $822,614.75 | -7.4% | |
| Jun 5, 2018 | IRWD Ironwood Pharmaceuticals Inc | Olanoff Lawrence S | Director | Sell | 2,000 | $17.62 | $35,240.00 | -4.4% | |
| Jun 5, 2018 | IRWD Ironwood Pharmaceuticals Inc | McHugh Julie53 | Director | Sell | 1,500 | $17.62 | $26,430.00 | -1.6% | |
| Jun 5, 2018 | EBS Emergent Biosolutions Inc. | Hauer Jerome M | Director | Sell | 8,375 | $52.16 | $436,876.01 | -40.0% | |
| Jun 5, 2018 | ESPR Esperion Therapeutics, Inc. | Biotech Target N V55 | 10% Owner | Buy | 60,000 | $38.47 | $2,308,440.00 | +2.0% | |
| Jun 5, 2018 | TLPH Talphera, Inc. | Edwards Mark G | Director | Buy | 5,000 | $3.35 | $16,735.00 | +1.7% | |
| Jun 4, 2018 | PCRX Pacira Biosciences, Inc. | Scranton Richard | Chief Scientific Officer | Sell | 1,367 | $33.02 | $45,138.34 | -10.1% | |
| Jun 4, 2018 | PCRX Pacira Biosciences, Inc. | Reinhart Charles A. III64 | Chief Financial Officer | Sell | 708 | $33.02 | $23,378.16 | -8.1% | |
| Jun 4, 2018 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 801 | $33.02 | $26,449.02 | -7.7% | |
| Jun 4, 2018 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 135,478 | $85.13 | $11,532,564.75 | -0.1% | |
| Jun 4, 2018 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | CAO And General Counsel | Sell | 2,040 | $33.02 | $67,360.80 | -9.6% | |
| Jun 4, 2018 | PCRX Pacira Biosciences, Inc. | Hastings Paul J75 | Director | Sell | 771 | $33.90 | $26,136.90 | -21.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.